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Abstract
Postpartum Depression (PPD) is highly prevalent among women in low and middle
income countries (LMICs). World Heath Organization has recognised interpersonal
Psychotherapy (IPT) as the first line treatment for the postpartum depression. The
primary aim of this review is to evaluate the effectiveness of IPT alone or in
combination with pharmacotherapy or other psychosocial therapies for treating
depressive symptoms in women with postpartum depression. The generated evidence
from this review will help to inform policies in relation to the treatment of
postpartum depression in LMICs.
1 | BACKGROUND
Depression is the most common mental health condition affecting
perinatal women and mothers (Hanlon, 2013). It is estimated that
15–85% of women experience postpartum blues within 10 days of
giving birth which is a subsequent risk factor for postpartum
depression (Pearlstein, Howard, Salisbury, & Zlotnick, 2009). Evi-
dence suggests that one out of seven women suffer from postpartum
depression (PPD; American Psychiatric Association, 2013). In
psychiatric nomenclature, postpartum depression is defined as a
major depressive disorder with a specifier of postpartum onset.
According to the Diagnostic Statistical Manual‐5 (DSM‐5; American
Psychiatric Association, 2013), PPD is defined as, ‘a major depression
episode during pregnancy or within 4 weeks of delivery’. Whereas,
the International Classification of Diseases‐10 (ICD‐10) guidelines
state that the onset of postpartum depression is considered to be
within 6 weeks after delivery (WHO, 2016a). This condition is twice
more prevalent in low middle income countries (LMICs) as compared
to high income countries (Gajaria and Ravindran, 2018)
PPD is known to affect mothers regardless of the fact that they
may have had an easy or problematic pregnancy. It has been
reported that approximately 19% of mothers from LAMICs will
experience significant depressive symptoms during the first 3
months after giving birth. Postpartum depression in LAMICs is
highly prevalent affecting one out of five women (Gelaye, Rondon,
Araya, & Williams Michelle, 2016). The prevalence rate of PPD in
LMICs is 31.8% which is higher than developed countries, that is,
21.5%. Futhermore, the prevalence of PPD in LMICs among rural
women is higher than the rural women of developed countries
(Fisher et al., 2012).
Women experiencing postpartum depression generally may
exhibit symptoms such as depressed mood, anxiety, feelings of guilt
or inadequacy, inability to cope, loss of control, intrusive presence of
compulsive thoughts, irrational fears and despair (American
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Psychiatric Association, 2013). Moreover, postpartum depression can
predispose to chronic or recurrent depression, which may affect the
mother ‒ infant relationship and child's growth and development
(Miniati et al., 2014). As per the literature, mother's with previous or
recurrent depression are more prone to have the positive signs of
depression even in postpartum period because of the alteration of
the chemical balance in channels called as neurotransmitters
(Hanlon, 2013). Mothers suffering from PPD do not enjoy their baby
and often believe that they are bad parents. There could be thoughts
related to harming self or the baby CMHA 2014. Further, children
of mothers with postpartum depression have greater cognitive,
behavioral and interpersonal problems compared with children of
non‐depressed mothers (Slomian, Honvo, Emonts, Reginster, &
BruyÃ¨re, 2019).
Pregnancy is a sensitive period where various bio psychosocial
variants that influence the psychology of women (Slomian, Honvo,
Emonts, Reginster, & BruyÃ¨re, 2019). The significant predictors
causing PPD include biological factors. Studies demonstrated that
women who are younger were more likely to experience
postpartum depression (Ghaedrahmati, Kazemi, Kheirabadi, Ebra-
himi, & Bahrami, 2017). Additionally, women with glucose
metabolism disorders were at risk of developing postpartum
depression (Huang et al., 2015). Moreover changes in role
transitions and interpersonal factors (e.g., partnership satisfaction,
social support) during or after pregnancy (Martini, 2015; Yuksel &
Aydin, 2015). Not only are these factors impacting on the mental
health and wellbeing of women, several social factors such as
unmarried mothers and unplanned pregnancy, perceived lack of
support from partners, parents, relatives and friends during the
postpartum period and impaired interpersonal relationships
between women with postpartum depression and their spouses
(Chien, Tai, & Yeh, 2012; Ghaedrahmati, Kazemi, Kheirabadi,
Ebrahimi, & Bahrami, 2017; Gurber, Baumeler, Grob, Surbek, &
Stadlmayr, 2017; Ludermir, Lewis, Valongueiro, de Araujo, &
Araya, 2010) have been shown to contribute towards PPD among
women in both LAMICs and high income countries. Moreover,
mothers with lower socioeconomic status and the primigravida
mothers often experiences more incidence related to postpartum
depression. The pertaining reasons for postpartum mothers
residing in LMICs often experience financial burden, lack of family
support, thus resulting into poor marital relationships and hence
causing postpartum depression (Bener, Gerber, & Sheikh, 2012).
People living in poverty in LMICs usually do not have access to
health services, good nutrition or clean environment. They also
face challenges of overcrowding and poor housing conditions
which further adds layers of stress during and after pregnancy
(Coast, Leone, Hirose, & Jones, 2012).
There are no viable guidelines in low‐ and middle‐income
countries for treating postpartum depression. Hence WHO
suggests integrating mental health services with primary care so
as to reduce the treatment gap for LAMICs. The usual treatment
for PPD involves psychotherapy and antidepressants. Due to
concerns of infant exposure to antidepressants, the preferred
choice of treatment for mothers is psychotherapy (Stuart &
O'Hara, 2012). Interpersonal psychotherapy (IPT) has been
suggested as the most relevant to postpartum depression as IPT
targets the specific interpersonal problems experienced by women
in the postpartum period (Gao, Chan, Li, Chen, & Hao, 2010; Stuart
& O'Hara, 2012). IPT is based on the premise that interpersonal
problems encountered during pregnancy along with various
hormonal changes results into possible symptoms of depression.
Treatment modalities delivered by mental health care profes-
sionals in low and high middle income countries for mothers with
PPD can help achieve the positivity in terms of better therapeutic
outcomes along with psychosocial improvement. Many studies
have demonstrated the efficacy of IPT in depression over other
psychological treatments (Bolton et al., 2003; Mufson et al., 2004;
Markowitz & Weissman, 2012; Beeber et al., 2013; Posmontier,
Neugebauer, Stuart, Chittams, & Shaughnessy, 2016). Various
organizations such as the American Psychiatric Association (2013)
and the National Institute for Health and Clinical Excellence:
Guidance (2014), have recognized IPT as an efficacious psycholo-
gical therapy. Despite the growing number of empirical studies on
postpartum depression, there is a lack of robust systematic
evidence on efficacy of IPT to treat PPD among LMICs. Therefore,
this systematic review will determine the usefulness of IPT to treat
PPD among mothers in LMICs.
1.1 | Description of the condition
Post partum depression is a non‐psychotic depressive episode in
which a women experiences symptoms of sadness, anxiety, lone-
liness, anhedonia, despondency, emotional lability, crying spells,
anger or rage during or within 6 months after childbirth. It is
different from postpartum blues as the latter has similar symptoms
but usually resolves in few days without any treatment. Post partum
depression if left unattended can have adverse effects. It not just
challenges the way women has to take care of her offspring but also
greatly affects her own daily self care activities (NIMH, 2013). The
mother with depression has increased likelihood of committing
suicide. Prolonged depression in mother can hamper mother‐infant
bonding, breastfeeding and infant care (WHO 2008). WHO estimates
the prevalence rate of PPD to be 10% which reach up to 15–20% in
developing countries (WHO 2008). The common determinants of
PPD in LMICs is low socio‐economic status, lack of social support,
resentment due to the sex of the baby resulting into poor relation-
ship with partner or mother‐in‐law (Shidhaye & Giri, 2014). The
treatment of PPD involves pharmacotherapy, psychotherapy and
sometimes both.
1.2 | Description of the intervention
IPT is a brief time‐limited psychotherapy in which the focus of the
treatment is current concerns and improving interpersonal
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relationships (Markowitz & Weissman, 2004). IPT has proven
efficacious in the treatment of affective disorders, anxiety disorders,
eating disorders, post traumatic stress disorder and depression
(Omay & Stuart, 2013). IPT has wide adaptability. It can be provided
in all settings, including hospitals and community settings. It can be
given individually as well as in group (WHO, 2013). IPT is based on
the principle that relationships and life events impact on mood. It was
developed by Gerald Klerman and Myrna Weissman for major
depression in the 1970s and has since been adapted for other mental
disorders. The four problem areas explored in IPT (Klerman &
Weissman, 1993; Omay & Stuart, 2013; WHO, 2016a) are grief, role
disputes, life changes/role transition, and loneliness/social isolation/
Interpersonal deficits. Phases of IPT include initial, middle and
termination phase.
• Initial phase: This includes 1–3 initial sessions. The important tasks of
this phase are taking the complete history of the client and building
rapport. The therapist makes the diagnosis during this phase by using
any standard tool for depression. Out of four problematic areas, both
therapist and the client mutually decide to pick one or two areas
which are of concern and will be addressed in subsequent sessions.
○ Grief: In this problem area, the therapist works on complicated
bereavement and helps the client to compete normal cycle of
grieving.
○ Role dispute: This problem area is chosen in case of unsatisfied
interpersonal relationships and non‐reciprocal role expecta-
tions between two persons.
○ Role transitions: This problem area is chosen when there are
major role transitions or role changes such as a new job, new
relationship or change in socio‐economic status or health etc.
Adaptive coping strategies are encouraged in the client.
○ Interpersonal deficits: This area is chosen when no other
interpersonal problem area is identified. Often, there is a long
history of impoverished interpersonal relationships.
• Middle phase: The middle phase is conducted from 4th
to 13th sessions. As suggested by Klerman,one of the
interpersonal problematic area is worked upon by assessing
mal‐adaptive responses in each problem area (Klerman &
Weissman, 1993).
• Termination phase: The final phase last from 14 to 16
sessions. Therapist and the patient review their treatment
course and future treatment needs (Markowitz & Weiss-
man, 2004).
On the basis of duration of IPT, it can be of two types:
1. Standard IPT: The originally developed IPT has a duration of
12–16 sessions
2. Brief IPT: Brief IPT has only eight sessions. It was developed in
the paucity of evidence linking increased duration to better
treatment outcomes. It helps the clients to take benefit of IPT in
fewer sessions in case they have some constraints (Swartz, Grote,
& Graham, 2014).
DOMAIN IPT IPT‐B
Number of sessions 12‐16 8
Initial Phase 3 2
Middle Phase 7‐11 5
Termination 2‐3 1
IPT is a flexible therapy. It can be given in various formats
such as:
1. Individual IPT
2. Group IPT
3. Couples IPT
4. Telephone IPT (Markowitz & Weissman, 2004)
Settings for IPT:
1. Health care settings
2. Community settings (Markowitz & Weissman, 2004)
IPT can be delivered by the following personnel:
1. Specialist providers (trained in IPT) (WHO, 2016b)
• Psychiatrists
• Psychologists
• Social workers
• Mental health nurses
2. Non‐specialist providers who have received training in IPT
(WHO, 2016a)
• Community workers
• General physicians
• Nurses
• Graduates with social or behavioral science degrees
1.3 | How the intervention might work
Psychotherapy is a better treatment than pharmacotherapy for
depression as there are fewer relapses and lesser premature
termination of treatment (Hunsley, Elliott, & Therrien, 2013). Emerging
evidence suggests better treatment adherence & decreased suicides if
psychotherapy is added along with medication for the treatment of
depression (Hunsley, Elliott, & Therrien, 2013). Comparison of various
types of psychotherapies like cognitive behavior therapy (CBT),
cognitive therapy, behavior therapy, play therapy, psychodynamic
therapy, family therapy, problem solving therapy, supportive therapy
and IPT have been examined in a number of clinical trials (Stamou,
García‐Palacios, & Botella, 2018). CBT and IPT are more efficacious in
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treating depression as compared to other therapies (Cuijpers, 2016).
Though IPT and CBT have equal or nearly equal effectiveness
(Cuijpers, 2016; Power & Freeman, 2012), IPT has some added
advantages over CBT (WHO, 2012). IPT can be given by
non‐ specialized trained persons (Van Ginneken et al., 2013;
WHO, 2016a). It can also be delivered telephonically (Bleiberg &
Markowitz, 2005; O'Hara, Stuart, Gorman, & Wenzel, 2000). Unlike
other therapies, the flexible approach of IPT increases its scope in
terms of accessibility and affordability to a larger population. That is
why, WHO has recommended IPT as the first line treatment for
depression for pregnant and breastfeeding mothers with moderate‐
severe depressive disorder (WHO, 2016b) (Figure 1).
The logic model has been adapted from Ludwig's systems
model (Von Bertalanffy, 1971), where different factors influencing
the outcome of treatment strategy (IPT) on postpartum depression
are identified in LMICs. Potential influencing factors such as
existing literature and evidence, WHO guidelines and predisposing
factors in LMICs for the occurrence of PPD are presented in Input.
The intervention for the treatment of PPD could be IPT alone or
IPT with pharmacotherapy or IPT in combination with other
psychological/psychosocial interventions in general health settings
or community based settings. Mode of delivery could be face to
face or telephonic conversation. IPT can be provided by Specia-
lized health workers such as Psychiatrist, Psychologist or Mental
health nurses or non‐specialized general health workers such as
General physicians, Nurses and Social workers who are trained in
IPT. IPT can be given in groups or individually. When 6–10
members are part of the therapy at one time, it is called Group‐
IPT. The activities also include differentiation on the basis of
duration of the therapy, that is, Standard IPT which of 12–16
weeks and Brief IPT, that is, of 8 weeks. The primary outcome of
giving IPT would be decrease in symptoms severity among the
mothers suffering from PPD. The secondary outcomes can fall
under maternal outcomes and couple outcomes. Maternal out-
comes can be measured in the form of improved mother‐infant
bonding, decreased anxiety of the mother and no future relapse.
IPT can lead to better couple outcomes in relation to better
marital adjustments and improved sexual life. Hence providing IPT
can lead to improved mental health services and mental health
outcomes. It also impacts the community at large for providing
accessible and affordable mental health treatment.
1.4 | Why it is important to do this review
PPD in LMICs is under‐acknowledged and under‐researched (Coast,
Leone, Hirose, & Jones, 2012). This review is important as previous
reviews have not focused primarily on IPT especially in LMICs.
Moreover, lack of resources in health care facilities and lags of
treatment gaps are the major reasons for considering the treatment
modalities especially in LMICs (Rathod et al., 2017. Few of the
previous reviews and meta‐analysis have evaluated the effectiveness
of all psychosocial and psychological treatments on postpartum
depression (Dennis, 2005; O'Connor, Rossom, Henninger, Groom, &
Burda, 2016; Sockol, Epperson, & Barber, 2011). These reviews had
very few trials for the effectiveness of IPT on PPD, as a result no
conclusive evidence was reported regarding the effectiveness of IPT
on PPD. Existing reviews have focused on depressive symptoms
reduction only (Dennis, 2005; Sockol, Epperson, & Barber, 2011).
They did not study the efficacy of the intervention such as mode of
IPT, duration of IPT (number of sessions) and combination of IPT and
pharmacotherapy. Only one systematic review was conducted which
specifically examined the effectiveness of IPT on PPD (Miniati
et al., 2014). Other related outcomes such as maternal‐infant
F IGURE 1 Logic Model concerning the effcetiveness of Interpersonal psychotherapy to improve postpartum depression outcomes and
improved mental health services in LMICs (Von Bertalanffy, 1971)
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relationship, social adjustment, social support, couple and infant
outcomes and harmful effects of IPT were not assessed. Further,
another review studied the effects of dyadic relationship focused
interventions on the mother‐infant relationships and child
outcomes, but did not provide any substantial evidence as to
whether improvement in mother ‐infant relationship was due to
reduced postpartum depression or developmental outcomes (Tsivos,
Rachel, Sanders, & Anja, 2015). Other reviews have focused on
prevention of postpartum depression rather that treatment (Boath,
Bradley, & Henshaw, 2004; Dennis, 2005; Morrell et al., 2016).
It has been reported by the World Health Organization (WHO)
that the availability of specialized and general health workers dealing
with mental health in LMICs is grossly insufficient. This raises concerns
and therefore person's with mental health disabilities may not get the
treatment required or the service due to a lack of resources
(WHO, 2016a). Persons with mental health disabilities may not access
services as there the evidence suggests that these are readily
available. In view of these factors, the WHO Mental Health Gap
Action Program (mhGAP) has recommended the scaling up of services
for mental, neurological and substance use disorders, especially in
LMICs (WHO, 2016b). Among the psychological therapies, WHO has
recommended and also published a manual on group IPT for
depression that can be administered by non‐specialists providers in
mental health but have some training in IPT (WHO, 2016b).
World Health Organization (WHO, 2016b) recommends that
evidence based psychological interventions such as IPT and CBT
should be the first line treatment for pregnant and breast‐feeding
women with moderate‐severe depression. While CBT can only be
delivered by specialized and trained psychologist, individual IPT can
be delivered by mental health professionals such as physicians,
psychologists, nurses and social health workers. Further, group IPT
can be delivered by supervised facilitators who may not have
received previous training in mental health (WHO, 2016b). Therefore
in line with this idea and goals of WHO's Comprehensive Mental
Health Action Plan 2013–2020 (WHO, 2013), IPT can be suggested
as the most accessible and affordable therapy among all psychothera-
pies which can be delivered in general healthcare and community
based settings by non‐specialized individuals (WHO, 2016b).
Therefore, this present review will focus on the effectiveness
of IPT alone or in combination with pharmacotherapy for treating
depressive symptoms. The present review will be useful in
generating evidence on the efficacy of IPT in treating postpartum
depression. The generated evidence from this review could be
used to inform policies in relation to treating postpartum women
with depressive symptoms in LMICs.
2 | OBJECTIVES
2.1 | Primary objective
a) What is the effectiveness of IPT alone or in combination with
pharmacological therapy and/or other psychological and psychosocial
interventions in reducing depressive symptoms in women diagnosed
with postpartum depression?
2.2 | Secondary objectives
b) What is the effectiveness of IPT according to the mode, that is,
individual, group, conjoint and telephonic; on reducing depressive
symptoms in postpartum depression?
c) What is the effectiveness of standard IPT (16 sessions) versus
brief IPT (8–12 sessions) on reducing depressive symptoms in
postpartum depression?
3 | METHODS
3.1 | Criteria for considering studies for this review
3.1.1 | Types of studies
We plan to identify and assess experimental, quasi‐experimental and
factorial designs where the primary or secondary aim is to find out
the effectiveness of IPT for reducing depressive symptoms in women
diagnosed with postpartum depression. Study designs such as case
reports, case series, reviews and non‐original studies such as
editorials, book reviews, commentaries, and letters to editors, will
be excluded.
Designs will include:
• Randomized controlled trial in which post‐partum mothers with
depression are randomly assigned to intervention and comparison
conditions.
1. Interventions includes Individual or Group Interpersonal psy-
chotherapy
2. Comparators include usual/standard care or pharmacotherapy
or IPT (individual or group) with pharmacotherapy or other
psycho‐social interventions or other psycho‐social interventions
with pharmacotherapy.
• Quasi‐experimental trials in which the mothers with depression
are assigned to groups non‐randomly.
1. Interventions includes individual or group interpersonal psy-
chotherapy
2. Comparators include usual/standard care or pharmacotherapy
or IPT (individual or group) with pharmacotherapy or other
psycho‐social interventions or other psycho‐social interventions
with pharmacotherapy.
For randomized and quasi‐experimental trials, studies with
significant baseline differences in the primary outcome measures
will be excluded.
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• Mixed methods where only quantitative components will be included.
• Factorial designs, where IPT and pharmacotherapy is compared to
psychosocial interventions along with pharmacotherapy.
Single group designs that measure pre and post outcomes will be
excluded.
3.1.2 | Types of participants
The specific population of interest is postpartum mothers in LMICs
diagnosed with depression developed during pregnancy or within
6 weeks post‐delivery, identified either through clinical diagnosis
(DSM‐IV, ICD‐10) or self‐reported measures, for example, Beck
Depression Inventory (BDI), EPDS (Edinburg Postnatal Depression
Scale), Public Health Questionnaire (PHQ‐9), Hamilton Rating Scale
for Depression (HRSD), Postpartum Depression Scale (PPDS), Major
Depression Inventory (MDI), Inventory to Diagnose Depression
(IDD), Center for Epidemiological Studies Depression Scale (CES‐D)
and Zung Self rating depression scale (SDS).
Our review will be international in scope and will apply to LMICs.
3.1.3 | Types of interventions
Interventions for the review will include IPT alone or IPT in
combination with Pharmacological treatment given to women with
postpartum depression.
The studies will be divided into categories to examine the
different modes of delivering IPT such as Group‐IPT vs Individual IPT,
Brief IPT/IPT‐B (8 weeks) vs IPT (12–16 weeks), Telephonic IPT vs
Standard IPT.
The studies will also be sub grouped into categories to examine
the effect of IPT intervention delivered by psychiatrist, psychologist,
trained nurses/social workers/health visitors and non‐specialized
trained volunteers from the community.
Treatment comparisons
1. IPT and usual or standard care (includes wait list controls)
2. IPT and pharmacotherapy
3. IPT alone and IPT with pharmacotherapy
4. IPT and combination of psychological and psychosocial interventions
5. IPT and pharmacotherapy compared with psychological and
psychosocial interventions with pharmacotherapy
3.1.4 | Types of outcome measures
Primary outcomes
Authors expect that depressive symptoms such as severity, symptom
remission, recovery status and relapse in the primary studies will be
measured through clinical diagnosis (DSM or ICD criteria) or self‐
reported measures, for example, Beck Depression Inventory (BDI), EPDS
(Edinburg Postnatal Depression Scale), Public Health Questionnaire
(PHQ‐9), Hamilton Rating Scale for Depression (HRSD), Postpartum
Depression Scale (PPDS), Major Depression Inventory (MDI), Inventory
to Diagnose Depression (IDD), Centre for Epidemiological Studies
Depression Scale (CES‐D) and Zung Self rating depression scale (SDS).
Secondary outcomes
• Maternal outcomes: Mother‐infant bonding/attachment, anxiety,
social support, postpartum adjustment, social adjustment, transi-
tion back to work.
• Couple outcomes: Marital adjustment, sexual interest.
• Adverse effects outcomes: Suicide attempts, suicides, number of
hospitalizations, duration of hospitalization, lost workdays, etc.
Duration of follow‐up
In order to combat the risk for symptom severity and relapse, acute
IPT is never terminated but concluded at the minimum in 8 weeks
and maximum in 16 weeks. In untreated cases, the maintenance
phase including monthly scheduled sessions may continue after-
wards. Hence, the minimum duration of the follow‐up will be 8
weeks. Maximum duration is not limited.
Types of settings
All general health settings and community‐based settings will be
included. We will also include the study settings where telephone‐
based interventions are given.
3.2 | Search methods for identification of studies
Both published and unpublished studies will be considered eligible for
this review. There will be no language restrictions. Relevant studies will
be sourced through literature searches of European and American
bibliographic databases and general search engines. Gray literature will
also be sought. The following databases will be systematically searched:
• Cochrane Central Registry of Controlled Trials.
• PUBMED
• EMBASE
• PsycINFO
• ERIC (ProQuest)
• CINAHL
• Web of Science
The search strategy will firstly develop keywords, combined with
Boolean operators, to assess potentially relevant articles on the
PubMed database from 1970 until 2019 (see Appendix 2B). IPT was
developed in the 1970s, and so we will start our retrieval date from
there. Due to controlled vocabularies across each database, the search
strategy terms will be adjusted to compensate for different databases.
The thesaurus of each database will be checked to ensure no indexed
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terms are missed. Relevant thesaurus terms will be added to the search
strategy. We will report details of the adjustments used for other
databases in the completed review. The combination of keywords and
thesaurus terms will allow the search strategy to be implemented.
In addition to bibliographic database searches, we will attempt to
capture European grey literature through OpenGREY. The authors will
contact the experts in the field of IPT to identify the unpublished and
ongoing studies. A list of the inclusion criteria for the review will be sent
to these experts along with the request for studies. Any studies that
match the inclusion criteria will be considered for use in this review.
The reference lists of relevant articles will be hand searched and
any potentially relevant studies that are identified will also be
retrieved and considered for inclusion. Furthermore, bibliographies
and references of systematic reviews and meta‐analysis will also be
examined to identify relevant studies in this field. Clinical trials will
be sought using the resource ClinicalTrials.gov. This website lists
completed and ongoing clinical trials in the US and around the world.
Lastly, we will conduct an advanced Google search where we will
input the same keywords used in the bibliographic database search.
The first twenty pages of results will be screened. In addition, we will
conduct the search again prior to submission to ensure we have
collated the most recent data.
3.2.1 | Description of methods used in primary
research
Anticipated methods that studies are likely to employ include
random assignment to treatment/comparison and pre‐test post‐
test design. There will be randomized controlled designs where the
participants are randomly assigned to intervention or control
group and quasi‐experimental designs, where participants are
allocated to groups using non‐random methods but steps are taken
to control the confounders, for example, matching of groups,
measures to ensure baseline equivalence for main outcomes etc. It
is expected that treatment condition IPT will be compared
to either usual/standard care or pharmacological therapy/other
psychosocial therapies.
We will use the secondary outcomes separately in summary of
findings. if insufficient data is reported in the primary studies, then
narrative account of these outcomes will be provided.
Different studies may use different instruments for measuring
the outcomes. We will give careful consideration, whether outcomes
from different measures can be combined in meta‐analysis. Further,
sensitivity analysis will also be conducted.
3.3 | Data collection and analysis
3.3.1 | Selection of studies
In the first phase, two members of the review team will indepen-
dently review the titles and abstract to exclude the studies. Full text
of only those studies will be retrieved, for which there is agreement
between the two reviewers. If disagreement persists regarding
exclusion of the studies, a third member of the review committee will
be involved to resolve the disagreement.
Second phase will include review of full articles and determine
the eligibility based on inclusion criteria, which will be reviewed by
two independent members of the review team. Here again, in case of
any disagreement, third member of the review team will be
consulted.
The rationale for exclusion of the studies will be documented for
each full text article reviewed. All the studies will be uploaded in
Endnote/Mendeley citation tool. PRISMA diagram will be used to
present overall search and screening process.
Multiple reports of a single study
Multiple reports by a single study will be considered as one study. If
needed, authors of studies will be consulted for clarifying any doubt.
Multiple groups in a single study
Data from all the eligible intervention arms will be combined and
will be compared with the data from all the eligible control arms.
Further single pairwise comparison will be conducted in the
meta‐analysis.
If two or more interventions are compared with one control
group, then each intervention group will be analyzed separately &
sample size will be divided for comparison or control group in order
to avoid double counting.
Multiple measures of the same outcome
We will calculate mean standardized mean difference (SMD) for all
measures of the same outcome variable, with their pooled estimated
variance so that only one effect estimate can be contributed by each
study for the meta‐analysis.
Multiple point in time
For different point in time data, separate analysis will be conducted.
3.3.2 | Data extraction and management
Details of study coding categories
The studies meeting the inclusion criteria will be reviewed
thoroughly and important information will be extracted in tables.
Two members of the review team will extract the relevant data
from each included study into evidence table. Data abstraction
form will be designed to gather pertinent information from
included studies such as study population characteristics, setting,
intervention, comparators, study design, methods, results, risk of
bias, etc. One member of the team will review the data
abstraction for completeness and accuracy. In case of any
disagreement, discussion will be done to reach the consensus,
or another member of the team will be consulted to resolve the
disagreement.
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Coding categories will be as follows:
1. Publication characteristics:
• Publication type
• Author details
• Date
• Setting of study (country and place)
2. Participant information
• Age
• Country of residence
• Race/ethnicity
• Socioeconomic status
3. Intervention
• Type of intervention
• Mode of intervention
• Number of sessions
• Duration of follow up
4. Comparison
• Type of comparison
• Mode
• Number of sessions
• Duration of follow up
5. Outcome measures
• Maternal outcomes
• Couple outcomes
• Adverse effect outcomes
• Tool/instruments used for measurement of each outcome
construct
6. Results
7. Risk of bias assessment
• Random sequence generation
• Allocation concealment
• Blinding of participants
• Blinding of personnel
• Outcome assessment blinding
• Attrition bias (incomplete outcome data)
• Reporting bias (selective reporting)
8. Data analysis
• Information to compute effect size of each outcome
(a) Continuous outcome variable: Mean, SD, n for treatment
and control group
(b) Dichotomous outcome variable: number of events and
number of events for control and treatment group
• Effect size
• Significance level of effect size
3.3.3 | Assessment of risk of bias in included studies
For the assessment of risk of bias of included studies of randomized
trial designs, revised Cochrane risk of bias tool for randomized tool
(RoB 2.0; Higgins et al., 2016) will be used. Risk of bias will be
assessed on seven domains; sequence generation, allocation
concealment, blinding of participants and personnel, blinding of
outcome assessment, incomplete outcome data, selective outcome
reporting and other issues. Risk of bias will be judged as low risk, high
risk and unclear risk.
For quasi‐experimental studies the ROBINS‐1 tool (Risk of Bias in
Non‐randomized Studies‐of Interventions) will be used (Sterne
et al., 2016). Studies will be judged as low risk, moderate risk,
serious risk and critical risk.
Two trained members of the team will assess the risk of bias of
included studies independently. If studies do not report details to
assess the validity of design or study, it will be reported as risk of bias
to be unclear.
3.3.4 | Measures of treatment effect
For each separate comparison, we will perform meta‐analysis for
comparison, if two or more similar studies will be found for
comparison of variables of interest. RevMan and R software will be
used to conduct meta‐analysis, sub‐group analysis, sensitivity
analysis, and publication bias estimates.
The included studies will be first categorize based on study
designs (i.e., RCT vs quasi‐experimental), and then by interven-
tion type. For multi‐component interventions, we will determine
which arms are most relevant to our review objectives and meet
our inclusion criteria for meta‐analysis. In a three‐armed RCT
((a) IPT alone, (b) IPT and pharmacotherapy, (c) standard or usual
care), first we will include arms 1 and 2 in our analysis, and then
1 and 3 in our analysis. In a two‐armed multi‐component RCT
((a) IPT and pharmacotherapy, (b) no treatment) we will analyze
these studies separately from two‐armed single component RCT
((a) IPT alone, (b) standard or usual care).
Descriptions of all intervention arms per study will be presented
in “Characteristics of Included Studies” table.
Depending on the outcome, we will calculate the standardized
mean difference SMD (for continuous outcomes) or log odds ratio
(for dichotomous outcomes), which are appropriate for comparison
between groups across similar types of treatment effects.
Where studies report baseline and post‐intervention outcome
data, SMDs will be calculated using baseline adjusted mean
differences (i.e., mean change scores). Standard deviation for the
change score will be standardized using the raw standard deviation
within groups. In cases where authors do not report standard
deviation for change scores, a formula recommended by Lipsey and
Wilson (2001) will be used to estimate these figures.
Where multiple measures are reported for an outcome (e.g., self‐
reported depression) in a single study, we will synthesize all
measures of depression across all included studies, as this will allow
complex analyses.
We will attempt to pool all studies within a given study design
and or intervention category, assessing the same outcome, in the
same population group by conducting a random‐effects meta‐analysis
using Review Manager 5.3. We will generate τ2, or Tau2 to estimate
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the absolute value of true heterogeneity between studies. Moreover,
to ensure no unit‐of‐analysis errors are made, we will combine
groups to create a single pair‐wise comparisons for each meta‐
analysis. Where meta‐analysis is deemed inappropriate due to
substantial heterogeneity, we will summarize the findings of the
included studies narratively.
Where some relevant studies have repeated observations on
participants, several different outcome measures will be defined on
different periods of follow‐up: brief (0–8 weeks), medium (9–16
weeks), and follow‐up (<16 weeks), these different outcomes will be
analyzed separately.
A random‐effects meta‐analysis model will be used given the high
level of variation in effect sizes anticipated across studies due to the
wide diversity in the design, scale, and implementation of their
interventions related to IPT and/or their combination. Additionally,
heterogeneity will be examined using the I2 statistic, Chi2 test and
Tau2 (Deeks, Higgins, & Altman, 2017).
We will calculate pooled effect sizes separately for the posttest
comparison of IPT with usual care or no treatment or placebo, with
other psychological and psychosocial interventions and pharma-
cotherapy, combination treatment with IPT and pharmacology
compared with pharmacotherapy alone.
We aim to compare treatments; IPT, IPT with pharmacotherapy,
IPT and combination of psychological and psychosocial interventions.
3.3.5 | Unit of analysis issues
We will asses the unit of analysis errors for cluster randomized trials. If
a study is found to be having unit of analysis error, we will use corrected
standard error and confidence intervals. Further Intra‐class correlation
will also be estimated. Authors of the primary study will be contacted to
find out the accuarate measure f intra‐class correlation in order to
calculate the corrceted standard error. If authors will not respond then
intra‐class correlations will be estimated from the similar types of
studies and method of estimation will explained clearly in the review.
3.3.6 | Dealing with missing data
The standardized coding form includes information on missing data.
In the case that data are missing from documents study authors will
be contacted and original data will be sought. Where missing data
cannot be recovered, studies will be coded on methods used to cope
with missing data and any inherent assumptions made explicit. This
data will be included in the final analysis, with the potential impact on
findings discussed (Deeks, Higgins, & Altman, 2017).
3.3.7 | Assessment of heterogeneity
Heterogeniety is anticipated due to the difference in the type/mode
of IPT, study designs and study settings etc. To tackle such type of
heterogeneity, we will coduct the seprate anlaysis for diffrent
settings, study designs, intervention type/mode etc.
Further, a random‐effects meta‐analysis model will be used given
the high level of variation in effect sizes anticipated across studies
due to the wide diversity in the design, scale, and implementation of
their interventions related to IPT and/or their combination. hetero-
geneity will be examined using the I2 statistic, Chi2 test, Q statistics
and Tau2 (Deeks, Higgins, & Altman, 2017). Heterogeniety will be
considered as substatial if I2 statistics value is greater than 30% and
either T2 is greater than zero, or the p value for Chi2 test for
heterogeniety is <0.10.
3.3.8 | Assessment of reporting biases
In order to ascertain whether publication bias may be influencing
results a number of gray literature sources will be searched for
relevant material. Key authors will be contacted for unpublished
documents relevant to the research question. Trial registries
will also be searched (e.g., http://www.ctri.nic.in) from a range of
countries. A funnel plot will be produced to assess whether
publication bias is likely to be influencing overall results and, data
permitting, subgroup analyses will be conducted to examine
whether intervention effects vary by publication source (published
vs unpublished).
3.3.9 | Subgroup analysis and investigation
of heterogeneity
We will apply the random‐effects model in conducting the
subgroup analyses including all between and within subgroup
weighting for the specified characteristics below. With this
approach, we will estimate and report the variance in effect size
across the studies within each subgroup and pool these subgroup
estimates based on the assumption that the between study
variance is likely to be the same for all subgroups. Combined
mean effect estimates of the subgroups will be computed
based on the random‐effects weights and pooled tau2. Compar-
isons for statistically significant differences will be tested using
an analysis of variance Q statistic that follows a chi‐square
distribution.
We have identified subgroup analyses that would be most
appropriate to investigate heterogeneity (if data permits):
• Different modes of delivering IPT (Group‐IPT vs Individual IPT,
Brief IPT/IPT‐B [8 weeks] vs IPT [12–16 weeks], Telephonic IPT vs
Standard IPT)
• Effect of IPT intervention delivered by psychiatrist, psychologist,
trained nurses/social workers/health visitors and non‐specialized
trained volunteers from community
• Effect of IPT as per setting, for example, general health settings,
community‐based setting, telephone‐based interventions
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For both categorical and continuous variables, meta‐regression
will be used. However, it can be prone to overfitting when the
number of studies included in the analysis is quite small (van
Houwelingen, Arends, & Stijnen, 2002). Where there is insufficient
data to conduct meta‐regression, moderator analysis analogous to
ANOVA will be used for categorical factors.
3.3.10 | Sensitivity analysis
Where possible, sensitivity analyses will be conducted to examine a
range of factors that may impact the robustness of the meta‐analysis
results.
These factors include:
(a) Research designs (RCT or quasi‐RCT)
(b) Risk of bias (low, medium or high)
(c) Comparison conditions (e.g., different groups of comparison
conditions)
(d) Timing of the outcome (e.g., 8 weeks, 16 weeks)
Any additional issues identified during the review process will
also be analyzed. Where certain decisions are identified to have
potential influence on findings, sensitivity analysis will be
undertaken by performing analysis with certain subgroups
removed. The results of sensitivity analysis will be presented in
a summary table.
If due to any reason such as heterogeneity, very few similar
studies or outcome measures variability; each study findings will be
described separately.
Summary of findings and assessment of the certainty of the evidence
The summary of findings will be presented in the table based on
GRADE recommendations. The table will include outcome variables,
Quality of evidence, sample size of interventional and control group,
effect size and results.
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and/or Campbell.
You accept responsibility for maintaining the review in light of
new evidence, comments and criticisms, and other developments, and
updating the review at least once every five years, or, if requested,
transferring responsibility for maintaining the review to others as
agreed with the Coordinating Group.
Publication in the Campbell Library
The support of the Coordinating Group in preparing your review is
conditional upon your agreement to publish the protocol, finished
review, and subsequent updates in the Campbell Library. Campbell
places no restrictions on publication of the findings of a Campbell
systematic review in a more abbreviated form as a journal article either
before or after the publication of the monograph version in Campbell
Systematic Reviews. Some journals, however, have restrictions that
preclude publication of findings that have been, or will be, reported
elsewhere and authors considering publication in such a journal should
be aware of possible conflict with publication of the monograph version
in Campbell Systematic Reviews. Publication in a journal after
publication or in press status in Campbell Systematic Reviews should
acknowledge the Campbell version and include a citation to it. Note
that systematic reviews published in Campbell Systematic Reviews and
co‐registered with Cochrane may have additional requirements or
restrictions for co‐publication. Review authors accept responsibility for
meeting any co‐publication requirements.
I understand the commitment required to undertake a Campbell
review, and agree to publish in the Campbell Library. Signed on
behalf of the authors:
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APPENDIX B: INITIAL SEARCH TERMS
There will be two categories of keywords employed for this search.
The first category of terms will list keywords related to the condition
of interest—postpartum depression. Our review is only concerned
with postpartum depression, and use of pnd as a search term will find
articles relating to both postnatal depression and perinatal depres-
sion. Articles concerning perinatal depression will be discarded. The
second category of terms will relate to the intervention—IPT. The
third category, outcomes, has been omitted due to the limitation this
will place on sourcing relevant articles. Including keywords relating
to effectiveness will exclude studies that may incorporate other
indexed terms.
The search terms will be linked by use of the Boolean operator
AND, appearing as so:
Condition of Interest: “postpartum depressi*” OR “post‐partum
depressi*” OR “postnatal depressi*” OR “post‐natal depressi*” OR
ppd OR pnd
Intervention: psychotherap* OR therap* OR counsel*
The final search terms, including thesaurus terms, will be detailed
in the full review.
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